Huntsman Cancer Institute combines advances in cancer research with cancer treatment through clinical trials, which are closely monitored studies of new treatments administered to cancer patients. Nearly all the cancer treatments that are considered conventional today began with clinical trials; they are the way scientists improve cancer treatments. Clinical trials are an essential part of Huntsman Cancer Institute’s "lab-bench-to-bedside" philosophy of studying cancer in order to develop better cancer treatments.

Huntsman Cancer Institute initiates a new clinical trial when the treatment being tested looks like it may prove to be more effective or produce fewer side effects than current remedies, or if it will expand treatment options for cancer patients. However, the patient's best interest is always paramount, and scientific questions, though important, do not override concern for the well-being of the individual patient.

Because clinical trials are experimental, they have associated risks as well as possible benefits:

• Risks: Treatments may cause side effects and other health risks depending on the type of treatment and the patient's condition, similar to conventional cancer therapies.
• Benefits: Patients in clinical trials are among the first to receive new research treatments before they are widely available. Patients also have the satisfaction of knowing they are helping find new and better cancer treatments.

Those interested in enrolling in cancer clinical trials should consult their physicians to see whether participation in a clinical trial is appropriate in their situation. Patients should participate in a study only after they understand both the possible risks and benefits of doing so.